Page last updated: 2024-09-03

reboxetine and Apnea, Obstructive Sleep

reboxetine has been researched along with Apnea, Obstructive Sleep in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Azarbarzin, A; Lombardi, C; Marconi, M; Meriggi, P; Parati, G; Perger, E; Rosa, D; Sands, SA; Taranto Montemurro, L; Vicini, S; Wellman, A; Zanotti, L1
Azarbarzin, A; Baratto, C; Caravita, S; Castiglioni, P; Faini, A; Lombardi, C; Meriggi, P; Parati, G; Perger, E; Pini, L; Rosa, D; Soranna, D; Vicini, S; Zambon, A1
Bayon, V; Berger, M; Bradley, B; Dussez, R; Haba-Rubio, J; Heiniger, G; Heinzer, R; Lecciso, G; Marchi, NA; Siclari, F; Solelhac, G; Van Den Broecke, S1
Carberry, JC; Eckert, DJ; Grunstein, R; Lim, R; Wellman, A1

Trials

4 trial(s) available for reboxetine and Apnea, Obstructive Sleep

ArticleYear
Reboxetine Plus Oxybutynin for OSA Treatment: A 1-Week, Randomized, Placebo-Controlled, Double-Blind Crossover Trial.
    Chest, 2022, Volume: 161, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Polysomnography; Reboxetine; Severity of Illness Index; Sleep Apnea, Obstructive; Treatment Outcome

2022
Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation.
    Scientific reports, 2023, 02-23, Volume: 13, Issue:1

    Topics: Autonomic Nervous System; Blood Pressure Monitoring, Ambulatory; Heart Rate; Humans; Middle Aged; Reboxetine; Sleep Apnea, Obstructive

2023
Effect of oxybutynin and reboxetine on obstructive sleep apnea: a randomized, placebo-controlled, double-blind, crossover trial.
    Sleep, 2023, 07-11, Volume: 46, Issue:7

    Topics: Cross-Over Studies; Double-Blind Method; Humans; Male; Oxygen; Reboxetine; Sleep Apnea, Obstructive

2023
Reboxetine and hyoscine butylbromide improve upper airway function during nonrapid eye movement and suppress rapid eye movement sleep in healthy individuals.
    Sleep, 2019, 04-01, Volume: 42, Issue:4

    Topics: Adult; Airway Resistance; Australia; Butylscopolammonium Bromide; Cross-Over Studies; Double-Blind Method; Electromyography; Female; Humans; Male; Nose; Parasympatholytics; Pharyngeal Muscles; Pharynx; Polysomnography; Pressure; Reboxetine; Respiration; Scopolamine; Sleep; Sleep Apnea, Obstructive; Sleep, REM; Tongue; Wakefulness

2019